Agios Pharmaceuticals | AGIO - Market Capitalization

Stock Price
27.78
Daily Change
-0.15 -0.54%
Monthly
1.20%
Yearly
-19.20%
Q1 Forecast
26.59

Agios Pharmaceuticals reported $1.59B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 371.63B 37.4B Feb/2026
Agios Pharmaceuticals USD 2.33B 402M Sep/2025
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
Amgen USD 184.41B 32.48B Feb/2026
Arrowhead Research USD 4.77B 2.59B Sep/2025
Astellas Pharma JPY 4.02T 1.46T Feb/2026
AstraZeneca USD 233.07B 17.56B Sep/2025
Bayer EUR 27.23B 2.14B Sep/2025
Biogen USD 20.54B 2.13B Sep/2025
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Eli Lilly USD 1.02T 300.22B Feb/2026
Exelixis USD 10.79B 1.79B Sep/2025
Gilead Sciences USD 137.73B 184M Sep/2025
GlaxoSmithKline GBP 86.59B 22.54B Feb/2026
Incyte USD 16.56B 3.38B Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Merck USD 293.38B 83.74B Feb/2026
Moderna USD 10.09B 581M Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Novartis USD 303.91B 57.84B Feb/2026
Pfizer USD 147.57B 12.48B Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Vertex Pharmaceuticals USD 100.41B 13.91B Sep/2025